Raben David
Chief Medical Officer · 17 insider transactions on file
All transactions
| Date | Ticker | Company | Type | Shares | Price | Value | Filing |
|---|---|---|---|---|---|---|---|
| 2026-04-27 | BCAX | Bicara Therapeutics Inc. | Sale | 5,500 | $22.88 | $125,830.10 | filing |
| 2026-04-27 | BCAX | Bicara Therapeutics Inc. | Option exercise | 5,500 | $3.79 | $20,843.90 | filing |
| 2026-03-25 | BCAX | Bicara Therapeutics Inc. | Sale | 5,500 | $18.95 | $104,229.40 | filing |
| 2026-03-25 | BCAX | Bicara Therapeutics Inc. | Option exercise | 5,500 | $3.79 | $20,843.90 | filing |
| 2026-03-04 | BCAX | Bicara Therapeutics Inc. | Sale | 16,300 | $18.52 | $301,920.01 | filing |
| 2026-03-04 | BCAX | Bicara Therapeutics Inc. | Option exercise | 16,300 | $3.79 | $61,773.74 | filing |
| 2026-03-03 | BCAX | Bicara Therapeutics Inc. | Sale | 200 | $18.45 | $3,690.00 | filing |
| 2026-03-03 | BCAX | Bicara Therapeutics Inc. | Option exercise | 200 | $3.79 | $757.96 | filing |
| 2025-12-26 | BCAX | Bicara Therapeutics Inc. | Option exercise | 19,789 | $3.79 | $74,996.35 | filing |
| 2025-11-25 | BCAX | Bicara Therapeutics Inc. | Sale | 4,594 | $18.84 | $86,561.99 | filing |
| 2025-11-25 | BCAX | Bicara Therapeutics Inc. | Option exercise | 4,594 | $3.79 | $17,410.34 | filing |
| 2025-11-25 | BCAX | Bicara Therapeutics Inc. | Sale | 906 | $18.84 | $17,071.21 | filing |
| 2025-11-25 | BCAX | Bicara Therapeutics Inc. | Option exercise | 906 | $3.79 | $3,433.56 | filing |
| 2025-11-24 | BCAX | Bicara Therapeutics Inc. | Sale | 5,500 | $18.45 | $101,475.00 | filing |
| 2025-11-24 | BCAX | Bicara Therapeutics Inc. | Option exercise | 5,500 | $3.79 | $20,843.90 | filing |
| 2025-10-09 | BCAX | Bicara Therapeutics Inc. | Sale | 22,000 | $18.45 | $405,900.00 | filing |
| 2025-10-09 | BCAX | Bicara Therapeutics Inc. | Option exercise | 22,000 | $3.79 | $83,375.60 | filing |
Insider transactions from SEC Form 4 filings via EDGAR. Names appear as filed and aren't normalized across issuers.